Alpha 2.0
Login Register
» Authors » Peter C Keng

Peter C Keng

Explore the profile of Peter C Keng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 1095
Followers 0
Related Specialties
Oncology
Cell Biology
Biochemistry
Top 10 Co-Authors
Yuhchyau Chen
Soo Ok Lee
Ying Tsai
Mingjing Shen
Xiaodong Chen
Michael A OReilly
Yongbing Chen
Yi-Jang Lee
Rongying Zhu
Lijun Xu
Published In
Am J Physiol Lung Cell Mol Physiol
Int J Radiat Oncol Biol Phys
Exp Cell Res
Int J Oncol
Prostate
Affiliations
Soon will be listed here.
Recent Articles
1.
Retraction Note: Radiation-induced glucocorticoid receptor promotes CD44 + prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling
Chen F, Chen X, Ren Y, Weng G, Keng P, Chen Y, et al.
J Mol Med (Berl) . 2021 Dec; 100(1):149. PMID: 34888709
No abstract available.
2.
Retraction notice to "Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancer" [Biochim. Biophys. Acta, Mol. Cell Res. Volume 1865, Issue 12, December 2018, Pages...
Zhu R, Yang X, Xue X, Shen M, Chen F, Chen X, et al.
Biochim Biophys Acta Mol Cell Res . 2021 Aug; 1868(11):119097. PMID: 34371295
No abstract available.
3.
Retraction notice to "FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells" [BBA - Molecular and Cell Biology of Lipids 1863/3 (March 2018) 313-322]
Shen M, Tsai Y, Zhu R, Keng P, Chen Y, Chen Y, et al.
Biochim Biophys Acta Mol Cell Biol Lipids . 2021 May; 1866(8):158946. PMID: 33933375
No abstract available.
4.
[Corrigendum] Increased infiltration of macrophages to radioresistant lung cancer cells contributes to the development of the additional resistance of tumor cells to the cytotoxic effects of NK cells
Shen M, Chen Y, Xu L, Zhu R, Xue X, Tsai Y, et al.
Int J Oncol . 2020 Sep; 57(4):1072-1073. PMID: 32945362
Subsequently to the publication of the above paper, the authors have realized that the western blots featured in Fig. 5B were inadvertently copied across from Fig. 4B owing to an...
5.
Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer
Chen X, Chen F, Ren Y, Weng G, Keng P, Chen Y, et al.
Prostate . 2020 May; 80(9):727. PMID: 32379952
No abstract available.
6.
Corrigendum to "In vitro-induced M2 type macrophages induces the resistance of prostate cancer cells to cytotoxic action of NK cells"[Exp Cell Res 364 (2018) 113-123]
Xu L, Shen M, Chen X, Yang D, Tsai Y, Keng P, et al.
Exp Cell Res . 2020 Apr; 391(1):112006. PMID: 32331849
No abstract available.
7.
Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer
Chen X, Chen F, Ren Y, Weng G, Keng P, Chen Y, et al.
Prostate . 2019 Jul; 79(12):1386-1398. PMID: 31334877
Background: Despite the overall success of radiotherapy, a significant number of patients develop radioresistance, which leads to local regional recurrence and distant metastasis. We studied whether repeated radiation treatment promotes...
8.
Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling
Chen F, Chen X, Ren Y, Weng G, Keng P, Chen Y, et al.
J Mol Med (Berl) . 2019 Jun; 97(8):1169-1182. PMID: 31187175
We observed cancer stem cell (CSC) population increase in radioresistant LNCaP (LNCaPR18) and C4-2 (C4-2R26) prostate cancer (PCa) cells compared with respective parental cells. Since the CD44 level increase was...
9.
IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2
Chen X, Chen F, Ren Y, Weng G, Xu L, Xue X, et al.
J Cancer Res Clin Oncol . 2019 Apr; 145(6):1471-1484. PMID: 31020420
Purpose: To study an association between IL-6 signaling and resistance to radiotherapy of prostate cancer (PCa) and explore the molecular mechanisms involved. Methods: IL-6 expressing C4-2 and CWR22Rv1 (C4-2IL-6/CWRIL-6) and...
10.
NFκB and TNFα as individual key molecules associated with the cisplatin-resistance and radioresistance of lung cancer
Zhu R, Xue X, Shen M, Tsai Y, Keng P, Chen Y, et al.
Exp Cell Res . 2018 Dec; 374(1):181-188. PMID: 30508513
Cisplatin-resistant (A549CisR and H292CisR) and radioresistant (A549R26 and H292R22) sub-line non-small cell lung cancer (NSCLC) cells were developed in our lab by long term treatment of parental cells with cisplatin...